Jeremy L Warner1, Andrew J Cowan2, Aric C Hall2, Peter C Yang2. 1. Vanderbilt University, Nashville, TN; Fred Hutchinson Cancer Research Center and University of Washington School of Medicine, Seattle, WA; University of Wisconsin School of Medicine and Public Health, Madison, WI; Massachusetts General Hospital, Boston, MA Jeremy.warner@vanderbilt.edu. 2. Vanderbilt University, Nashville, TN; Fred Hutchinson Cancer Research Center and University of Washington School of Medicine, Seattle, WA; University of Wisconsin School of Medicine and Public Health, Madison, WI; Massachusetts General Hospital, Boston, MA.
Abstract
PURPOSE: Cancer care involves extensive knowledge about numerous chemotherapy drugs and chemotherapy regimens. This information is constantly evolving, and there has been no freely available, comprehensive, centralized repository of chemotherapy information to date. METHODS: We created an online, freely accessible, ad-free, collaborative wiki of chemotherapy information entitled HemOnc.org to address the unmet need for a central repository of this information. This Web site was developed with wiki development software and is hosted on a cloud platform. Chemotherapy drug and regimen information (including regimen variants), as well as other information of interest to hematology/oncology professionals, is housed on the site in a fully referenced and standardized format. Accredited users are allowed to freely contribute information to the site. RESULTS: From its inception in November 2011, HemOnc.org has grown rapidly and most recently has detailed information on 383 drugs and 1,298 distinct chemotherapy regimens (not counting variants) in 92 disease subtypes. There are regularly more than 2,000 visitors per week from the United States and international locations. A user evaluation demonstrated that users find the site useful, usable, and recommendable. CONCLUSION: HemOnc.org is now the largest free source of chemotherapy drug and regimen information and is widely used. Future enhancements, including more metadata about drugs and increasingly detailed efficacy and toxicity information, will continue to improve the value of the resource.
PURPOSE: Cancer care involves extensive knowledge about numerous chemotherapy drugs and chemotherapy regimens. This information is constantly evolving, and there has been no freely available, comprehensive, centralized repository of chemotherapy information to date. METHODS: We created an online, freely accessible, ad-free, collaborative wiki of chemotherapy information entitled HemOnc.org to address the unmet need for a central repository of this information. This Web site was developed with wiki development software and is hosted on a cloud platform. Chemotherapy drug and regimen information (including regimen variants), as well as other information of interest to hematology/oncology professionals, is housed on the site in a fully referenced and standardized format. Accredited users are allowed to freely contribute information to the site. RESULTS: From its inception in November 2011, HemOnc.org has grown rapidly and most recently has detailed information on 383 drugs and 1,298 distinct chemotherapy regimens (not counting variants) in 92 disease subtypes. There are regularly more than 2,000 visitors per week from the United States and international locations. A user evaluation demonstrated that users find the site useful, usable, and recommendable. CONCLUSION: HemOnc.org is now the largest free source of chemotherapy drug and regimen information and is widely used. Future enhancements, including more metadata about drugs and increasingly detailed efficacy and toxicity information, will continue to improve the value of the resource.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Jona Kräenbring; Tika Monzon Penza; Joanna Gutmann; Susanne Muehlich; Oliver Zolk; Leszek Wojnowski; Renke Maas; Stefan Engelhardt; Antonio Sarikas Journal: PLoS One Date: 2014-09-24 Impact factor: 3.240
Authors: Jeremy L Warner; Dmitry Dymshyts; Christian G Reich; Michael J Gurley; Harry Hochheiser; Zachary H Moldwin; Rimma Belenkaya; Andrew E Williams; Peter C Yang Journal: J Biomed Inform Date: 2019-06-22 Impact factor: 6.317
Authors: Michael V Sherer; Diana Lin; Kartikeya Puri; Neil Panjwani; Zhigang Zhang; James D Murphy; Erin F Gillespie Journal: JCO Clin Cancer Inform Date: 2019-10
Authors: Florian Borchert; Andreas Mock; Aurelie Tomczak; Jonas Hügel; Samer Alkarkoukly; Alexander Knurr; Anna-Lena Volckmar; Albrecht Stenzinger; Peter Schirmacher; Jürgen Debus; Dirk Jäger; Thomas Longerich; Stefan Fröhling; Roland Eils; Nina Bougatf; Ulrich Sax; Matthieu-P Schapranow Journal: Brief Bioinform Date: 2021-11-05 Impact factor: 11.622
Authors: Samuel M Rubinstein; Tarsheen Sethi; Neeta K Venepalli; Bishal Gyawali; Candice Schwartz; Donna R Rivera; Peter C Yang; Jeremy L Warner Journal: JCO Clin Cancer Inform Date: 2021-01
Authors: Fernando Suarez Saiz; Corey Sanders; Rick Stevens; Robert Nielsen; Michael Britt; Leemor Yuravlivker; Anita M Preininger; Gretchen P Jackson Journal: JCO Clin Cancer Inform Date: 2021-01
Authors: Jeremy L Warner; Matthew J Rioth; Kenneth D Mandl; Joshua C Mandel; David A Kreda; Isaac S Kohane; Daniel Carbone; Ross Oreto; Lucy Wang; Shilin Zhu; Heming Yao; Gil Alterovitz Journal: J Am Med Inform Assoc Date: 2016-03-27 Impact factor: 7.942